These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28776529)

  • 1. Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India.
    Prajapati K; Mishra V; Desai M; Solanki R; Naik P
    Int J Mycobacteriol; 2017; 6(3):289-295. PubMed ID: 28776529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensively drug-resistant tuberculosis: experience at the Tuberculosis Research Centre, Chennai, India.
    Thomas A; Joseph P; Nair D; Rao DV; Rekha VV; Selvakumar N; Jaggarajamma K; Balambal R
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1323-5. PubMed ID: 22283888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing a case of extensively drug-resistant (XDR) pulmonary tuberculosis in Singapore.
    Phua CK; Chee CB; Chua AP; Gan SH; Ahmed AD; Wang YT
    Ann Acad Med Singap; 2011 Mar; 40(3):132-5. PubMed ID: 21603731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic accuracy of time to sputum culture conversion in predicting cure in extensively drug-resistant tuberculosis patients: a multicentre retrospective observational study.
    Abubakar M; Ahmad N; Atif M; Ahmad I; Wahid A; Khan A; Saleem F; Ghafoor A
    BMC Infect Dis; 2022 Mar; 22(1):204. PubMed ID: 35236307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.
    Velayutham BV; Allaudeen IS; Sivaramakrishnan GN; Perumal V; Nair D; Chinnaiyan P; Paramasivam PK; Dhanaraj B; Santhanakrishnan RK; Navaneethapandian GP; Marimuthu MK; Kumar V; Kandasamy C; Dharuman K; Elangovan T; Narasimhan M; Rathinam S; Vadivelu G; Rathinam P; Chockalingam C; Jayabal L; Swaminathan S; Shaheed JM
    Clin Infect Dis; 2014 Nov; 59(10):e142-9. PubMed ID: 25028463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India.
    Chakraborty N; De C; Bhattacharyya S; Mukherjee A; Santra S; Banerjee D; Sarkar RN; Guha SK
    Trans R Soc Trop Med Hyg; 2010 Mar; 104(3):195-201. PubMed ID: 19828165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB.
    Kliiman K; Altraja A
    Eur Respir J; 2009 May; 33(5):1085-94. PubMed ID: 19164345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
    Abbate E; Vescovo M; Natiello M; Cufré M; García A; Gonzalez Montaner P; Ambroggi M; Ritacco V; van Soolingen D
    J Antimicrob Chemother; 2012 Feb; 67(2):473-7. PubMed ID: 22134348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
    Singla R; Caminero JA; Jaiswal A; Singla N; Gupta S; Bali RK; Behera D
    Eur Respir J; 2012 Apr; 39(4):956-62. PubMed ID: 21965225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment outcome of bedaquiline plus optimised background regimen in drug resistant tuberculosis patients.
    Barvaliya SV; Desai MK; Panchal JR; Solanki RN
    Indian J Tuberc; 2020 Apr; 67(2):222-230. PubMed ID: 32553316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data.
    Muñoz-Torrico M; Caminero Luna J; Migliori GB; D'Ambrosio L; Carrillo-Alduenda JL; Villareal-Velarde H; Torres-Cruz A; Flores-Ergara H; Martínez-Mendoza D; García-Sancho C; Centis R; Salazar-Lezama MÁ; Pérez-Padilla R
    Rev Port Pneumol (2006); 2017; 23(1):27-30. PubMed ID: 28043788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.
    Thomas TA; Shenoi SV; Heysell SK; Eksteen FJ; Sunkari VB; Gandhi NR; Friedland G; Shah NS
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1244-51. PubMed ID: 20843414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis.
    Payen MC; De Wit S; Martin C; Sergysels R; Muylle I; Van Laethem Y; Clumeck N
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):558-60. PubMed ID: 22325421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High correlation of clinical criteria in the diagnosis of drug-resistant TB and prevalence of ofloxacin resistance.
    Kumar R; Garg R; Kant S; Verma SK; Kushwaha RA; Kumar S; Jain A
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1354-1357. PubMed ID: 27725047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.